Cargando…
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
Transplantation of HLA mismatched hematopoietic stem cells in patients with severe combined immunodeficiency (SCID) can result in a selective engraftment of T cells of donor origin with complete immunologic reconstitution and in vivo tolerance. The latter may occur in the absence of clonal deletion...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191349/ https://www.ncbi.nlm.nih.gov/pubmed/7905018 |
Ejemplares similares
-
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
por: Haddad, Elie, et al.
Publicado: (2019) -
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation
por: Fürst, Daniel, et al.
Publicado: (2017) -
Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantation
por: Hunziker, Mireille, et al.
Publicado: (2021) -
The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012) -
HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors
por: Pession, Andrea, et al.
Publicado: (2011)